these results show that 8F4 is highly active against treatment-refractory primary human HLA-A2 + AML in established AML treatment NSG model. 8F4 treatment prolongs survival of mice with ...

Results show that the team created a new mouse breed, called NSG-Pro, that produces levels of human prolactin similar to those in patients with metastatic estrogen receptor-positive breast cancer.

The Jackson Laboratory imported the strain in 2015 in anticipation of distribution, but has since discontinued production of MISTRG mice. Fortunately for the research community, both the NSG ...

At issue in the lawsuit is MARC’s purchases from JAX of NOD-scid gamma (NSG™) mice, created by JAX by introducing genetic mutations into its nonobese diabetic (NOD) mice. NSG mice are severely ...

This new mouse model, called NSG-Pro, supports greatly enhanced growth of implanted ER-positive human breast cancers. Molecular pathway analyses of the tumors revealed that prolactin collaborates ...